Tocilizumab, a humanized monoclonal antibody, targets and neutralizes the interleukin-6 receptor (IL-6R). By blocking the interaction of IL-6 with IL-6R, Tocilizumab effectively inhibits both classical and trans-signaling pathways. This antibody is primarily utilized in the therapeutic management of rheumatoid arthritis, leveraging its ability to modulate inflammatory responses. Additionally, Tocilizumab has demonstrated significant efficacy in research focused on severe cases of COVID-19, highlighting its potential in addressing cytokine release syndrome and related complications. This makes it a valuable tool for both clinical and research applications in immune-mediated inflammatory disorders.
Tocilizumab, a humanized monoclonal antibody, targets and neutralizes the interleukin-6 receptor (IL-6R). By blocking the interaction of IL-6 with IL-6R, Tocilizumab effectively inhibits both classical and trans-signaling pathways. This antibody is primarily utilized in the therapeutic management of rheumatoid arthritis, leveraging its ability to modulate inflammatory responses. Additionally, Tocilizumab has demonstrated significant efficacy in research focused on severe cases of COVID-19, highlighting its potential in addressing cytokine release syndrome and related complications. This makes it a valuable tool for both clinical and research applications in immune-mediated inflammatory disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
